CSIMarket
 


Psychemedics Corp  (PMD)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

PMD's Revenue Growth by Quarter and Year

Psychemedics's Revenue results by quarter and year




PMD Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 5.70 6.44 5.34
III Quarter September 5.09 6.52 6.67 5.17
II Quarter June 5.06 6.51 6.09 3.31
I Quarter March 5.86 6.51 5.71 7.54
FY   16.01 25.24 24.91 21.36



PMD Revenue third quarter 2023 Y/Y Growth Comment
Psychemedics Corp reported decline in Revenue in the third quarter 2023 by -21.92% to $ 5.09 millions, from the same quarter in 2022.
The contraction in the third quarter 2023 Psychemedics Corp's Revenue compares unfavorably to the Company's average Revenue growth of 1.52%.

Looking into third quarter 2023 results within Medical Laboratories industry 19 other companies have achieved higher Revenue growth. While Psychemedics Corp' s Revenue fall of -21.92% ranks overall at the positon no. 1957 in the third quarter 2023.




PMD Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - -11.49 % 20.6 % -38.76 %
III Quarter September -21.92 % -2.25 % 29.01 % -47.51 %
II Quarter June -22.27 % 6.9 % 83.99 % -64.37 %
I Quarter March -9.98 % 14.01 % -24.27 % -23.22 %
FY   - 1.32 % 16.62 % -43.31 %

Financial Statements
Psychemedics's third quarter 2023 Revenue $ 5.09 millions PMD's Income Statement
Psychemedics's third quarter 2022 Revenue $ 6.52 millions Quarterly PMD's Income Statement
New: More PMD's historic Revenue Growth >>


PMD Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -12.58 % -3.45 % 3.29 %
III Quarter September 0.61 % 0.15 % 9.52 % 56.19 %
II Quarter June -13.65 % 0 % 6.65 % -56.1 %
I Quarter March 2.81 % 1.09 % 6.93 % -13.53 %
FY (Year on Year)   - 1.32 % 16.62 % -43.31 %




Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #20
Healthcare Sector #329
Overall #1957

Revenue Y/Y Growth Statistics
High Average Low
58.15 % 1.52 % -44.8 %
(Mar 31 2017)   (Mar 31 2021)
Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #20
Healthcare Sector #329
Overall #1957
Revenue Y/Y Growth Statistics
High Average Low
58.15 % 1.52 % -44.8 %
(Mar 31 2017)   (Mar 31 2021)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Psychemedics's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
56.13 % 0.88 % -56.03 %
(Sep 30 2020)  


PMD's III. Quarter Q/Q Revenue Comment
Psychemedics Corp achieved in the III. Quarter 2023 below company average Revenue growth of 0.61% quarter on quarter, to $ 5.09 millions.

III. Quarter 2023 PMD's Revenue sequential growth were contradictory, albeit beneath the average rise of 0.88 %, yet it demonstrates absolute acceleration relative to the 0.15% in the III. Quarter a year ago

Within Medical Laboratories industry 14 other companies have achieved higher Revenue quarter on quarter growth. While Psychemedics's Revenue growth quarter on quarter, overall rank is 1680.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #15
Healthcare Sector #292
Overall #1680
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #15
Healthcare Sector #292
Overall #1680
Revenue Q/Q Growth Statistics
High Average Low
56.13 % 0.88 % -56.03 %
(Sep 30 2020)  


PMD's III. Quarter Q/Q Revenue Comment
Psychemedics Corp achieved in the III. Quarter 2023 below company average Revenue growth of 0.61% quarter on quarter, to $ 5.09 millions.

III. Quarter 2023 Revenue Q/Q growth seem to be paradoxical, although beneath the regular growth of 0.88 %, yet it shows real acceleration measured to the 0.15% in the same quarter a year ago

Within Medical Laboratories industry 14 other companies have achieved higher Revenue quarter on quarter growth. While Psychemedics's Revenue growth quarter on quarter, overall rank is 1680.


Psychemedics's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Revenue 12 Months Ending $ 21.71 $ 23.14 $ 24.59 $ 25.24 $ 25.97
Y / Y Revenue Growth (TTM) -16.41 % -11.45 % -4.33 % 1.33 % 9.09 %
Year on Year Revenue Growth Overall Ranking # 1225 # 1001 # 677 # 1240 # 1676
Seqeuential Revenue Change (TTM) -6.16 % -5.91 % -2.57 % -2.82 % -0.6 %
Seq. Revenue Growth (TTM) Overall Ranking # 1957 # 2061 # 2103 # 2071 # 2011




Cumulative Revenue growth Comment
Psychemedics's cumulative 12 months Revenue continue to fall, but on the faster rate at -16.41% year on year, at Sep 30 2023 compare to the -11.45% decrease at Jun 30 2023. If the Psychemedics's fiscal year would end at Sep 30 2023, annual Revenue would be $22 millions.

In the Healthcare sector 247 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1001 to 1225.

Revenue TTM Q/Q Growth Statistics
High Average Low
58.15 %
1.52 %
-44.8 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 20
Healthcare Sector # 248
Overall # 1225

Revenue TTM Y/Y Growth Statistics
High Average Low
58.15 %
1.52 %
-44.8 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 20
Sector # 329
S&P 500 # 1957
Cumulative Revenue growth Comment
Psychemedics's cumulative 12 months Revenue continue to fall, but on the faster rate at -16.41% year on year, at Sep 30 2023 compare to the -11.45% decrease at Jun 30 2023. If the Psychemedics's fiscal year would end at Sep 30 2023, annual Revenue would be $22 millions.

In the Healthcare sector 247 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1001 to 1225.

Revenue TTM Q/Q Growth Statistics
High Average Low
58.15 %
1.52 %
-44.8 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 20
Healthcare Sector # 248
Overall # 1225

Revenue TTM Y/Y Growth Statistics
High Average Low
58.15 %
1.52 %
-44.8 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 20
Sector # 329
S&P 500 # 1957




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PMD's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for PMD's Competitors
Revenue Growth for Psychemedics's Suppliers
Revenue Growth for PMD's Customers

You may also want to know
PMD's Annual Growth Rates PMD's Profitability Ratios PMD's Asset Turnover Ratio PMD's Dividend Growth
PMD's Roe PMD's Valuation Ratios PMD's Financial Strength Ratios PMD's Dividend Payout Ratio
PMD's Roa PMD's Inventory Turnover Ratio PMD's Growth Rates PMD's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2023
Procyon Corporation-0.22%$ -0.221 millions
Amedisys Inc -0.31%$ -0.314 millions
Karyopharm Therapeutics Inc -0.38%$ -0.376 millions
Establishment Labs Holdings Inc -0.50%$ -0.505 millions
Opko Health Inc -0.64%$ -0.639 millions
Integra Lifesciences Holdings Corp-0.72%$ -0.719 millions
Healthcare Services Group Inc -0.75%$ -0.748 millions
Phibro Animal Health Corporation-0.77%$ -0.772 millions
Bellicum Pharmaceuticals Inc -0.89%$ -0.890 millions
Prestige Consumer Healthcare Inc -1.12%$ -1.125 millions
Sharecare Inc -1.13%$ -1.127 millions
Lifevantage Corp-1.14%$ -1.140 millions
Organon and Co -1.17%$ -1.171 millions
Optinose Inc -1.27%$ -1.270 millions
Baxter International Inc -1.72%$ -1.723 millions
Puma Biotechnology Inc -1.73%$ -1.727 millions
Blueprint Medicines Corporation-1.76%$ -1.763 millions
Standard Biotools Inc -1.92%$ -1.918 millions
Pacira Biosciences inc -2.11%$ -2.114 millions
Bristol myers Squibb Company-2.25%$ -2.246 millions
Aurinia Pharmaceuticals Inc -2.27%$ -2.266 millions
Abbott Laboratories-2.56%$ -2.565 millions
Enhabit Inc -2.79%$ -2.785 millions
Novocure Limited-2.81%$ -2.807 millions
Uniqure N v -2.90%$ -2.899 millions
Vaso Corporation-2.92%$ -2.925 millions
Scientific Industries Inc -3.16%$ -3.165 millions
Akumin Inc -3.21%$ -3.205 millions
Syros Pharmaceuticals Inc -3.32%$ -3.315 millions
Viatris Inc -3.34%$ -3.342 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com